9:46 AM
 | 
Jun 08, 2018
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Oncologie raises $16.5M for dual U.S.-China strategy

Cancer company Oncologie Ltd. (Cayman Islands) raised $16.5 million in a seed financing led by Pivotal bioVenture Partners China. Nan Fung Life Sciences, China Merchant Bank Investments and Volcanics Ventures also joined the round.

Oncologie plans to develop in-licensed cancer assets in China and the U.S. simultaneously. Oncologie founder, President and CEO Laura Benjamin told BioCentury the company is focusing on cancers prevalent in Asia -- including gastric, liver and lung cancers.

According to Benjamin, the company used most of the seed funding on...

Read the full 399 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >